Novaquest Pharma Opportunities Fund Iii, L.p. - Net Worth and Insider Trading

Novaquest Pharma Opportunities Fund Iii, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Novaquest Pharma Opportunities Fund Iii, L.p. owns 1 companies in total, including Revance Therapeutics Inc (RVNC) .

Click here to see the complete history of Novaquest Pharma Opportunities Fund Iii, L.p.’s form 4 insider trades.

Insider Ownership Summary of Novaquest Pharma Opportunities Fund Iii, L.p.

Ticker	Comapny	Transaction Date	Type of Owner
RVNC	Revance Therapeutics Inc	2014-02-05	10 percent owner

Novaquest Pharma Opportunities Fund Iii, L.p. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Novaquest Pharma Opportunities Fund Iii, L.p. Ownership Network

Ownership Network List of Novaquest Pharma Opportunities Fund Iii, L.p.

No Data

Ownership Network Relation of Novaquest Pharma Opportunities Fund Iii, L.p.

Novaquest Pharma Opportunities Fund Iii, L.p. Owned Company Details

What does Revance Therapeutics Inc do?

Who are the key executives at Revance Therapeutics Inc?

Novaquest Pharma Opportunities Fund Iii, L.p. is the 10 percent owner of Revance Therapeutics Inc. Other key executives at Revance Therapeutics Inc include Chief Financial Officer Tobin Schilke , President Dustin S Sjuts , and SVP & GC & Secretary Dwight Moxie .

Revance Therapeutics Inc (RVNC) Insider Trades Summary

Over the past 18 months, Novaquest Pharma Opportunities Fund Iii, L.p. made no insider transaction in Revance Therapeutics Inc (RVNC). Other recent insider transactions involving Revance Therapeutics Inc (RVNC) include a net sale of 124,284 shares made by Mark J Foley , a net sale of 38,865 shares made by Tobin Schilke , and a net sale of 64,379 shares made by Dwight Moxie .

In summary, during the past 3 months, insiders sold 0 shares of Revance Therapeutics Inc (RVNC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 297,646 shares of Revance Therapeutics Inc (RVNC) were sold and 30,000 shares were bought by its insiders, resulting in a net sale of 267,646 shares.

Revance Therapeutics Inc (RVNC)'s detailed insider trading history can be found in Insider Trading Tracker table.

Revance Therapeutics Inc Insider Transactions

No Available Data

Novaquest Pharma Opportunities Fund Iii, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Novaquest Pharma Opportunities Fund Iii, L.p.. You might contact Novaquest Pharma Opportunities Fund Iii, L.p. via mailing address: 4208 Six Forks Road, Suite 920, Raleigh Nc 27609.

Discussions on Novaquest Pharma Opportunities Fund Iii, L.p.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.